Lin Hong-Liang, Lin Shyr-Yi, Lin Ying-Ku, Ho Hsiu-O, Lo Yo-Wen, Sheu Ming-Thau
College of Pharmacy, Taipei Medical University, Taiwan, ROC.
Eur J Pharm Biopharm. 2008 Sep;70(1):289-301. doi: 10.1016/j.ejpb.2008.03.021. Epub 2008 Apr 22.
This study attempted to characterize the influence of core and coating formulations on the release profiles to establish in vitro/in vivo correlations of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture based on three core tablet formulations (A-core: HPMC 50+4000 cps, B-core: E10M, and C-core: K100M) coated with various thicknesses of a semipermeable ethylcellulose membrane plasticized with HPMC 606 (Pharmacoat 606) at different ratios with/without adding various amounts of water to dissolve it in the coating solution. Drug release behaviors were investigated using apparatus II in four media of pH 1.2 solution, pH 6.8 buffer, deionized water, and a NaCl solution rotated at 75, 100, and 150 rpm. Pilot studies of the in vivo pharmacokinetics were conducted as well for comparison with the in vitro results. Results demonstrated that drug release from the three kinds of core tablets in deionized water increased with an increasing stirring rate, and decreased with an increasing viscosity grade of HPMC used in the core formulations. A significant promotion of drug release from core tablets was observed for the three levels of NaCl media in comparison with that in deionized water. Results further demonstrated that a slightly slower release rate in pH 1.2 solution and a faster release rate in pH 6.8 buffer than that in deionized water were observed for the A-core and B-core tablets, with the former being slower than the latter. However, similar release rates in the three kinds of media were observed for C-core tablets, but they were slower than those for the A- and B-core tablets. Dissolution of coated tablets showed that the controlling membrane was ruptured by osmotic pressure and swelling which activated drug release with a lag time. The lag time was not influenced by the pH value of the release medium or by the rotation speeds. The lag time increased with a higher coating level, but decreased with the addition of the hydrophilic plasticizer, Pharmacoat 606, and of the water amount in the coating solution. The lag time also increased with a higher concentration of NaCl in the medium. The release rate after the lag time was determined by the extent of retardation of gelation of HPMC in the core tablet based on the ionic strength of the medium. Results of the three pilot crossover studies for the exemplified pulsatile systems indicated that the lag time for the in vivo plasma profile was well correlated with that determined from the in vitro release profile in pH 1.2 solution and the in vivo release rate was better reflected by that performed in pH 6.8 buffer.
本研究旨在基于三种核心片剂配方(A-核心:羟丙甲纤维素50 + 4000厘泊,B-核心:乙基纤维素10M,C-核心:羟丙甲纤维素K100M),通过在不同比例下添加/不添加不同量的水以使其溶解在包衣溶液中,用羟丙甲纤维素606(药用羟丙甲纤维素606)增塑的不同厚度的半透性乙基纤维素膜包衣,来表征核心和包衣配方对释放曲线的影响,以建立基于膜破裂的脉冲式给药系统的脉冲模式的体外/体内相关性。在pH 1.2溶液、pH 6.8缓冲液、去离子水和氯化钠溶液这四种介质中,使用装置II在75、100和150转/分钟的转速下研究药物释放行为。还进行了体内药代动力学的初步研究,以便与体外结果进行比较。结果表明,三种核心片剂在去离子水中的药物释放随着搅拌速度的增加而增加,随着核心配方中使用的羟丙甲纤维素粘度等级的增加而降低。与去离子水中相比,在三种氯化钠介质水平下观察到核心片剂的药物释放有显著促进作用。结果进一步表明,对于A-核心和B-核心片剂,在pH 1.2溶液中的释放速率略慢,在pH 6.8缓冲液中的释放速率比在去离子水中快,前者比后者慢。然而,C-核心片剂在三种介质中的释放速率相似,但比A-核心和B-核心片剂慢。包衣片剂的溶出表明,控制膜因渗透压和溶胀而破裂,从而激活药物释放并伴有滞后时间。滞后时间不受释放介质的pH值或转速的影响。滞后时间随着包衣层数的增加而增加,但随着亲水性增塑剂药用羟丙甲纤维素606和包衣溶液中水的量的添加而减少。滞后时间也随着介质中氯化钠浓度的增加而增加。滞后时间后的释放速率由基于介质离子强度的核心片剂中羟丙甲纤维素凝胶化的阻滞程度决定。针对示例性脉冲式系统进行